Skip to content

The efficacy of Jazar capsule, on menopausal symptoms and sexual disorder of menopausal women

The efficacy of Jazar capsule, a Persian medicine product, on menopausal symptoms and sexual disorder of menopausal women

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180705040349N1
Enrollment
90
Registered
2018-10-09
Start date
2018-08-23
Completion date
Unknown
Last updated
2018-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menopausal symptoms and sexual disorder of menopausal women. Menopausal and female climacteric states

Interventions

Intervention 1: Intervention group: Jazar capsule 500mg, made by Talaye sabz Tooba company, Including powder of chastetree seeds, fennel seeds and carrot seeds, two capsules in the morning and two at

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 60 Years

Inclusion criteria

Inclusion criteria: Married women that their spouses are present at home at least for half of each month Age between 45-60 No menstrual periods for at least 12 months and no longer than 5 years literate or having a literate person at home Menopause but not due to illness or uterus and ovaries resection At least 2 hot flashes per day FSFI = 26 Willing to attend the project Normal Pap smear during the last two years

Exclusion criteria

Exclusion criteria: Sensitivity to the medicine or placebo Use of other medications or other therapies to reduce the menopausal symptoms during the study Hormone intake for the past 6 months Diabetes or other serious illnesses Malignancy history Addiction to cigarettes, drugs or alcohol History of mental illness

Design outcomes

Primary

MeasureTime frame
Quality of life. Timepoint: Weeks 4, 8 and 10 after intervention. Method of measurement: Menopause quality of life questionnaire (MENQOL questionare).;Sexual function. Timepoint: Weeks 4, 8 and 10th after intervention beginning. Method of measurement: Female sexual function index questionare (FSFI questionare).

Secondary

MeasureTime frame
Vaginal maturation index (VMI). Timepoint: Before intervention and 10 weeks after intervention beginning. Method of measurement: Pap smear.;Vaginal PH. Timepoint: Before intervention and 10 weeks after intervention beginning. Method of measurement: PH-meter strip.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSousan Hafizi Moori

Tehran University of Medical Sciences

sou_hafizi@yahoo.com+98 21 8897 6527

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026